New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Saturday, Nov 21, 2026
Export PASG’s income statement to Excel — free account
Passage Bio, Inc.
PASG- EPS
- n/m
- Free cash flow
- n/m
Quarter to September 2026, against a year earlier
3.92
0.31
+8.59%
Follow PASG
Alert me
Where the cash went Fiscal 2025, year to Dec 31, 2025
Free cash flow was −$30.3M: capital expenditures were more than operating cash flow. Cash rose by $8.7M. What is a cash flow statement?
- Free cash flow
- −$30.3M
- Returned to shareholders
- $0.00
- Debt, net
- $0.00 borrowed
- Change in cash
- +$8.7M over the period
| Operating cash flow | −31.5 |
|---|---|
| Capital expenditures | +1.2 |
| Free cash flow | −30.3 |
| From investments, net | +39.0 |
| Change in cash | 8.7 |
Free cash flow
| FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow | −$40M | −$81M | −$127M | −$118M | −$78M | −$48M | −$32M |
| Capex | −$1.2M | −$1.1M | −$18M | −$2.3M | $0.0B | $0 | $1.2M |
| Free cash flow | −$41M | −$82M | −$145M | −$120M | −$78M | −$48M | −$30M |
Figures in millions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Net Income |
0.00 | (12.77) | (45.63) | (112.23) | (185.39) | (136.12) | (102.06) | (64.77) | (45.52) |
Depreciation & Amortization |
— | — | 0.13 | 1.43 | 4.32 | 4.45 | 1.69 | 1.55 | 0.86 |
Non Cash Items (Other) |
— | — | 11.55 | 15.84 | 42.77 | 21.95 | 16.77 | 11.05 | 9.16 |
Accounts Payable Change |
— | — | 0.40 | 4.59 | 2.20 | (5.41) | (2.79) | (0.56) | 1.88 |
Change in payables and accrued liability |
— | 0.21 | 2.02 | 12.20 | 3.98 | (7.34) | 0.66 | (4.96) | (2.05) |
Change in other assets and liabilities |
— | (8.57) | (8.36) | (2.34) | 5.24 | 4.26 | 7.47 | 9.72 | 4.17 |
Other operating activities |
0.00 | — | — | — | — | — | — | — | — |
Operating Cash Flow |
— | (18.57) | (39.90) | (80.52) | (126.88) | (118.21) | (78.26) | (47.96) | (31.51) |
Capital expenditures |
— | — | (1.19) | (1.15) | (17.64) | (2.27) | (0.15) | (0.03) | 1.17 |
Change in intangibles (net) |
— | — | (0.50) | (0.50) | (8.00) | (3.00) | — | — | — |
Short Term Investments Change (Net) |
— | — | — | (170.46) | (20.17) | 30.47 | 65.38 | 54.98 | 39.05 |
Investing cash flow |
— | (2.54) | (1.69) | (172.11) | (45.81) | 25.20 | 65.24 | 54.95 | 40.22 |
Equity Repurchase (Common, Net) |
— | — | 0.18 | 228.75 | 166.99 | 0.43 | 0.14 | 8.87 | 0.02 |
Equity Repurchase (Preffered, Net) |
— | — | 176.19 | — | — | — | — | — | — |
Other financial activities |
— | 2.73 | (0.76) | 16.47 | (0.34) | (1.79) | — | — | — |
Financing cash flow |
— | 45.97 | 175.60 | 228.75 | 166.66 | (1.35) | 0.14 | 8.87 | 0.02 |
Change in Cash |
— | 24.86 | 134.01 | (23.87) | (6.04) | (94.36) | (12.89) | 15.86 | 8.73 |
Beginning Cash |
— | — | 24.86 | 158.87 | 135.00 | 128.97 | 34.60 | 21.71 | 37.57 |
Ending Cash |
— | — | 158.87 | 135.00 | 128.97 | 34.60 | 21.71 | 37.57 | 46.30 |
Stock Based Compensation |
— | — | 1.45 | 14.58 | 32.69 | 18.95 | 10.92 | 5.82 | 3.00 |
Dividends Paid (Common) |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Assets Liabilities Change (Total) |
— | — | (5.94) | 14.44 | 11.42 | (8.49) | 5.34 | 4.20 | 4.00 |
Investments Change (Net) |
— | — | — | (170.46) | (20.17) | 30.47 | 65.38 | 54.98 | 39.05 |
Issuance/Purchase of Shares |
— | — | 176.37 | 228.75 | 166.99 | 0.43 | 0.14 | 8.87 | 0.02 |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 12, 2026